Two large studies have found a small increase in the absolute risk of rare types of blood clot in the head following a first dose of the AstraZeneca COVID-19 vaccine. An increased risk of a type called intracranial venous thrombosis only applied to individuals under 70 years of age. The […]
Read More
An advisory committee to the Centers for Disease Control and Prevention (CDC) is addressing the safety of the Johnson & Johnson COVID-19 vaccine today after the CDC and FDA recommended that states hold off on using it pending a detailed review of six cases of the same kind of rare but serious […]
Read More
The US, South Africa and European Union will temporarily stop the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting. Six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said. Johnson & Johnson […]
Read More
The incidence of venous thromboembolism (VTE) in nonhospitalized patients with COVID-19 was not significantly different from patients without the infectious disease, according to a new study published in JAMA Internal Medicine. National Institutes of Health guidelines recommend blood thinners to prevent blood clots in patients hospitalized with COVID-19. However, the new study provides […]
Read More
NEW YORK (Reuters Health) – Blood type A was associated with a greater risk of severe SARS-CoV-2 in one recent study and a higher risk of contracting the disease in another. “The two studies are complementary,” Dr. James Szymanski of Montefiore Medical Center and Albert Einstein College of Medicine in […]
Read More